Medicines planning

The licence and supporting evidence for ranibizumab biosimilars

29 June 2022A licensed ranibizumab biosimilar is available from Teva: Ongavia. Learn about the licensed indications and supporting evidence.

Understanding biological and biosimilar medicines

29 June 2022Biosimilar medicines are a type of biological medicine that offer the NHS opportunities to deliver better value for certain conditions

How to develop a Patient Group Direction

9 June 2022A step by step guide to help organisations and individuals navigate all stages of the PGD development process

Patient Group Direction use in remote consultations

3 February 2022Advice on managing PGDs during organisational changes to ensure continuity of safe care with overarching good governance.

Including more than one medicine in a Patient Group Direction

2 December 2021This article summarises the considerations required if more than one medicine is included within a PGD.

Using medicines at more than one location under a single PGD

16 November 2021A single PGD can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.

NHS prescription charges for PGDs or HMR 2012 exemptions

16 November 2021This article summarises the position regarding the levying of prescription charges for medicines supplied under a PGD.

New Product Evaluations

11 October 2021A list of new product evaluations that are freely available to NHS staff via the internet

Planning

Annual medicines planning

Our annual Prescribing Outlook outputs support planning, implementation and budget planning for medicines every year.

Repeat supply or administration of medicines under PGD

26 April 2021The below article details the position regarding use of a PGD to make repeat supplies/repeated administrations of a medicine.

SPS - Specialist Pharmacy Service

NHS